Loading…

MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy

Despite possessing limited protein-coding potential, long non-coding RNAs (lncRNAs) have been implicated in a myriad of pathologic conditions. Most well documented in cancer, one prominent intergenic lncRNA known as MALAT1 is notorious for its role in impacting epigenetic mechanisms. In this study,...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2018-04, Vol.8 (1), p.6526-15, Article 6526
Main Authors: Biswas, Saumik, Thomas, Anu Alice, Chen, Shali, Aref-Eshghi, Erfan, Feng, Biao, Gonder, John, Sadikovic, Bekim, Chakrabarti, Subrata
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c540t-d9bcfbba0e0b78d394ef03de9ee50610199cb6bc6cdf9d74163f9afb4d59f55a3
cites cdi_FETCH-LOGICAL-c540t-d9bcfbba0e0b78d394ef03de9ee50610199cb6bc6cdf9d74163f9afb4d59f55a3
container_end_page 15
container_issue 1
container_start_page 6526
container_title Scientific reports
container_volume 8
creator Biswas, Saumik
Thomas, Anu Alice
Chen, Shali
Aref-Eshghi, Erfan
Feng, Biao
Gonder, John
Sadikovic, Bekim
Chakrabarti, Subrata
description Despite possessing limited protein-coding potential, long non-coding RNAs (lncRNAs) have been implicated in a myriad of pathologic conditions. Most well documented in cancer, one prominent intergenic lncRNA known as MALAT1 is notorious for its role in impacting epigenetic mechanisms. In this study, we established a novel epigenetic paradigm for MALAT in diabetic retinopathy (DR) by employing siRNA-mediated MALAT1 knockdown in human retinal endothelial cells (HRECs), a Malat1 knockout animal model, vitreous humor from diabetic patients, pharmacological inhibitors for histone and DNA methylation, RNA immunoprecipitation, western blotting, and a unique DNA methylation array to determine glucose-related alterations in MALAT1 . Our findings indicated that MALAT1 is capable of impacting the expressions of inflammatory transcripts through its association with components of the PRC2 complex in diabetes. Furthermore, the vitreous humors from diabetic patients revealed increased expressions of MALAT1, TNF-α, and IL-6. Intriguingly, our DNA methylation array demonstrated that transient high glucose exposure in HRECs does not contribute to significant methylation alterations at CpG sites across the MALAT1 gene. However, global inhibition of DNA methyltransferases induced significant increases in MALAT1 and associated inflammatory transcripts in HRECs. Our findings collectively demonstrate the importance of MALAT1 in inflammation and epigenetic regulation in DR.
doi_str_mv 10.1038/s41598-018-24907-w
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5916949</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2031415971</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-d9bcfbba0e0b78d394ef03de9ee50610199cb6bc6cdf9d74163f9afb4d59f55a3</originalsourceid><addsrcrecordid>eNp9kUtr3DAURkVpaUKSP9BFMWTTjRs9bd8sAkOapoEphZKuhSRLEwVbmkh2Qv59NZ1pHl1UGwnuuZ90dRD6QPBngll3kjkR0NWYdDXlgNv64Q3ap5iLmjJK374476GjnG9xWYICJ_Ae7VFoQLSs20eX3xfLxTU5rRahulj7lQ128qb6aVfzoKaYquiqq-AGNY5q8jFUPlRfvNI7avIhrtV083iI3jk1ZHu02w_Qr68X1-ff6uWPy6vzxbI2guOp7kEbp7XCFuu26xlw6zDrLVgrcEMwATC60aYxvYO-5aRhDpTTvBfghFDsAJ1tc9ezHm1vbJiSGuQ6-VGlRxmVl68rwd_IVbyXAkgDHErAp11AinezzZMcfTZ2GFSwcc6SYkY2X9uSgh7_g97GOYUy3obCHes6aAtFt5RJMedk3dNjCJYbVXKrShZV8o8q-VCaPr4c46nlr5gCsC2QSymsbHq--z-xvwFUzJ_6</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2030838897</pqid></control><display><type>article</type><title>MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Biswas, Saumik ; Thomas, Anu Alice ; Chen, Shali ; Aref-Eshghi, Erfan ; Feng, Biao ; Gonder, John ; Sadikovic, Bekim ; Chakrabarti, Subrata</creator><creatorcontrib>Biswas, Saumik ; Thomas, Anu Alice ; Chen, Shali ; Aref-Eshghi, Erfan ; Feng, Biao ; Gonder, John ; Sadikovic, Bekim ; Chakrabarti, Subrata</creatorcontrib><description>Despite possessing limited protein-coding potential, long non-coding RNAs (lncRNAs) have been implicated in a myriad of pathologic conditions. Most well documented in cancer, one prominent intergenic lncRNA known as MALAT1 is notorious for its role in impacting epigenetic mechanisms. In this study, we established a novel epigenetic paradigm for MALAT in diabetic retinopathy (DR) by employing siRNA-mediated MALAT1 knockdown in human retinal endothelial cells (HRECs), a Malat1 knockout animal model, vitreous humor from diabetic patients, pharmacological inhibitors for histone and DNA methylation, RNA immunoprecipitation, western blotting, and a unique DNA methylation array to determine glucose-related alterations in MALAT1 . Our findings indicated that MALAT1 is capable of impacting the expressions of inflammatory transcripts through its association with components of the PRC2 complex in diabetes. Furthermore, the vitreous humors from diabetic patients revealed increased expressions of MALAT1, TNF-α, and IL-6. Intriguingly, our DNA methylation array demonstrated that transient high glucose exposure in HRECs does not contribute to significant methylation alterations at CpG sites across the MALAT1 gene. However, global inhibition of DNA methyltransferases induced significant increases in MALAT1 and associated inflammatory transcripts in HRECs. Our findings collectively demonstrate the importance of MALAT1 in inflammation and epigenetic regulation in DR.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/s41598-018-24907-w</identifier><identifier>PMID: 29695738</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/21 ; 13/89 ; 14/1 ; 38/109 ; 38/77 ; 38/90 ; 631/80/304 ; 64/60 ; 692/163/2743/137/138 ; 692/420 ; 82/51 ; Animal models ; Cancer ; CpG islands ; Deoxyribonucleic acid ; Diabetes ; Diabetes mellitus ; Diabetic retinopathy ; DNA ; DNA methylation ; Endothelial cells ; Epigenetics ; Humanities and Social Sciences ; Immunoprecipitation ; Inflammation ; Interleukin 6 ; multidisciplinary ; Retina ; Retinopathy ; Science ; Science (multidisciplinary) ; siRNA ; Tumor necrosis factor-α ; Vitreous humor ; Western blotting</subject><ispartof>Scientific reports, 2018-04, Vol.8 (1), p.6526-15, Article 6526</ispartof><rights>The Author(s) 2018</rights><rights>2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-d9bcfbba0e0b78d394ef03de9ee50610199cb6bc6cdf9d74163f9afb4d59f55a3</citedby><cites>FETCH-LOGICAL-c540t-d9bcfbba0e0b78d394ef03de9ee50610199cb6bc6cdf9d74163f9afb4d59f55a3</cites><orcidid>0000-0003-2139-3678</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2030838897/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2030838897?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29695738$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Biswas, Saumik</creatorcontrib><creatorcontrib>Thomas, Anu Alice</creatorcontrib><creatorcontrib>Chen, Shali</creatorcontrib><creatorcontrib>Aref-Eshghi, Erfan</creatorcontrib><creatorcontrib>Feng, Biao</creatorcontrib><creatorcontrib>Gonder, John</creatorcontrib><creatorcontrib>Sadikovic, Bekim</creatorcontrib><creatorcontrib>Chakrabarti, Subrata</creatorcontrib><title>MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>Despite possessing limited protein-coding potential, long non-coding RNAs (lncRNAs) have been implicated in a myriad of pathologic conditions. Most well documented in cancer, one prominent intergenic lncRNA known as MALAT1 is notorious for its role in impacting epigenetic mechanisms. In this study, we established a novel epigenetic paradigm for MALAT in diabetic retinopathy (DR) by employing siRNA-mediated MALAT1 knockdown in human retinal endothelial cells (HRECs), a Malat1 knockout animal model, vitreous humor from diabetic patients, pharmacological inhibitors for histone and DNA methylation, RNA immunoprecipitation, western blotting, and a unique DNA methylation array to determine glucose-related alterations in MALAT1 . Our findings indicated that MALAT1 is capable of impacting the expressions of inflammatory transcripts through its association with components of the PRC2 complex in diabetes. Furthermore, the vitreous humors from diabetic patients revealed increased expressions of MALAT1, TNF-α, and IL-6. Intriguingly, our DNA methylation array demonstrated that transient high glucose exposure in HRECs does not contribute to significant methylation alterations at CpG sites across the MALAT1 gene. However, global inhibition of DNA methyltransferases induced significant increases in MALAT1 and associated inflammatory transcripts in HRECs. Our findings collectively demonstrate the importance of MALAT1 in inflammation and epigenetic regulation in DR.</description><subject>13/21</subject><subject>13/89</subject><subject>14/1</subject><subject>38/109</subject><subject>38/77</subject><subject>38/90</subject><subject>631/80/304</subject><subject>64/60</subject><subject>692/163/2743/137/138</subject><subject>692/420</subject><subject>82/51</subject><subject>Animal models</subject><subject>Cancer</subject><subject>CpG islands</subject><subject>Deoxyribonucleic acid</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetic retinopathy</subject><subject>DNA</subject><subject>DNA methylation</subject><subject>Endothelial cells</subject><subject>Epigenetics</subject><subject>Humanities and Social Sciences</subject><subject>Immunoprecipitation</subject><subject>Inflammation</subject><subject>Interleukin 6</subject><subject>multidisciplinary</subject><subject>Retina</subject><subject>Retinopathy</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>siRNA</subject><subject>Tumor necrosis factor-α</subject><subject>Vitreous humor</subject><subject>Western blotting</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp9kUtr3DAURkVpaUKSP9BFMWTTjRs9bd8sAkOapoEphZKuhSRLEwVbmkh2Qv59NZ1pHl1UGwnuuZ90dRD6QPBngll3kjkR0NWYdDXlgNv64Q3ap5iLmjJK374476GjnG9xWYICJ_Ae7VFoQLSs20eX3xfLxTU5rRahulj7lQ128qb6aVfzoKaYquiqq-AGNY5q8jFUPlRfvNI7avIhrtV083iI3jk1ZHu02w_Qr68X1-ff6uWPy6vzxbI2guOp7kEbp7XCFuu26xlw6zDrLVgrcEMwATC60aYxvYO-5aRhDpTTvBfghFDsAJ1tc9ezHm1vbJiSGuQ6-VGlRxmVl68rwd_IVbyXAkgDHErAp11AinezzZMcfTZ2GFSwcc6SYkY2X9uSgh7_g97GOYUy3obCHes6aAtFt5RJMedk3dNjCJYbVXKrShZV8o8q-VCaPr4c46nlr5gCsC2QSymsbHq--z-xvwFUzJ_6</recordid><startdate>20180425</startdate><enddate>20180425</enddate><creator>Biswas, Saumik</creator><creator>Thomas, Anu Alice</creator><creator>Chen, Shali</creator><creator>Aref-Eshghi, Erfan</creator><creator>Feng, Biao</creator><creator>Gonder, John</creator><creator>Sadikovic, Bekim</creator><creator>Chakrabarti, Subrata</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2139-3678</orcidid></search><sort><creationdate>20180425</creationdate><title>MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy</title><author>Biswas, Saumik ; Thomas, Anu Alice ; Chen, Shali ; Aref-Eshghi, Erfan ; Feng, Biao ; Gonder, John ; Sadikovic, Bekim ; Chakrabarti, Subrata</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-d9bcfbba0e0b78d394ef03de9ee50610199cb6bc6cdf9d74163f9afb4d59f55a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>13/21</topic><topic>13/89</topic><topic>14/1</topic><topic>38/109</topic><topic>38/77</topic><topic>38/90</topic><topic>631/80/304</topic><topic>64/60</topic><topic>692/163/2743/137/138</topic><topic>692/420</topic><topic>82/51</topic><topic>Animal models</topic><topic>Cancer</topic><topic>CpG islands</topic><topic>Deoxyribonucleic acid</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetic retinopathy</topic><topic>DNA</topic><topic>DNA methylation</topic><topic>Endothelial cells</topic><topic>Epigenetics</topic><topic>Humanities and Social Sciences</topic><topic>Immunoprecipitation</topic><topic>Inflammation</topic><topic>Interleukin 6</topic><topic>multidisciplinary</topic><topic>Retina</topic><topic>Retinopathy</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>siRNA</topic><topic>Tumor necrosis factor-α</topic><topic>Vitreous humor</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Biswas, Saumik</creatorcontrib><creatorcontrib>Thomas, Anu Alice</creatorcontrib><creatorcontrib>Chen, Shali</creatorcontrib><creatorcontrib>Aref-Eshghi, Erfan</creatorcontrib><creatorcontrib>Feng, Biao</creatorcontrib><creatorcontrib>Gonder, John</creatorcontrib><creatorcontrib>Sadikovic, Bekim</creatorcontrib><creatorcontrib>Chakrabarti, Subrata</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Biswas, Saumik</au><au>Thomas, Anu Alice</au><au>Chen, Shali</au><au>Aref-Eshghi, Erfan</au><au>Feng, Biao</au><au>Gonder, John</au><au>Sadikovic, Bekim</au><au>Chakrabarti, Subrata</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2018-04-25</date><risdate>2018</risdate><volume>8</volume><issue>1</issue><spage>6526</spage><epage>15</epage><pages>6526-15</pages><artnum>6526</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>Despite possessing limited protein-coding potential, long non-coding RNAs (lncRNAs) have been implicated in a myriad of pathologic conditions. Most well documented in cancer, one prominent intergenic lncRNA known as MALAT1 is notorious for its role in impacting epigenetic mechanisms. In this study, we established a novel epigenetic paradigm for MALAT in diabetic retinopathy (DR) by employing siRNA-mediated MALAT1 knockdown in human retinal endothelial cells (HRECs), a Malat1 knockout animal model, vitreous humor from diabetic patients, pharmacological inhibitors for histone and DNA methylation, RNA immunoprecipitation, western blotting, and a unique DNA methylation array to determine glucose-related alterations in MALAT1 . Our findings indicated that MALAT1 is capable of impacting the expressions of inflammatory transcripts through its association with components of the PRC2 complex in diabetes. Furthermore, the vitreous humors from diabetic patients revealed increased expressions of MALAT1, TNF-α, and IL-6. Intriguingly, our DNA methylation array demonstrated that transient high glucose exposure in HRECs does not contribute to significant methylation alterations at CpG sites across the MALAT1 gene. However, global inhibition of DNA methyltransferases induced significant increases in MALAT1 and associated inflammatory transcripts in HRECs. Our findings collectively demonstrate the importance of MALAT1 in inflammation and epigenetic regulation in DR.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>29695738</pmid><doi>10.1038/s41598-018-24907-w</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0003-2139-3678</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-2322
ispartof Scientific reports, 2018-04, Vol.8 (1), p.6526-15, Article 6526
issn 2045-2322
2045-2322
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5916949
source Publicly Available Content Database; PubMed Central; Free Full-Text Journals in Chemistry; Springer Nature - nature.com Journals - Fully Open Access
subjects 13/21
13/89
14/1
38/109
38/77
38/90
631/80/304
64/60
692/163/2743/137/138
692/420
82/51
Animal models
Cancer
CpG islands
Deoxyribonucleic acid
Diabetes
Diabetes mellitus
Diabetic retinopathy
DNA
DNA methylation
Endothelial cells
Epigenetics
Humanities and Social Sciences
Immunoprecipitation
Inflammation
Interleukin 6
multidisciplinary
Retina
Retinopathy
Science
Science (multidisciplinary)
siRNA
Tumor necrosis factor-α
Vitreous humor
Western blotting
title MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A41%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MALAT1:%20An%20Epigenetic%20Regulator%20of%20Inflammation%20in%20Diabetic%20Retinopathy&rft.jtitle=Scientific%20reports&rft.au=Biswas,%20Saumik&rft.date=2018-04-25&rft.volume=8&rft.issue=1&rft.spage=6526&rft.epage=15&rft.pages=6526-15&rft.artnum=6526&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/s41598-018-24907-w&rft_dat=%3Cproquest_pubme%3E2031415971%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-d9bcfbba0e0b78d394ef03de9ee50610199cb6bc6cdf9d74163f9afb4d59f55a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2030838897&rft_id=info:pmid/29695738&rfr_iscdi=true